March 15 (Reuters) - Aralez Pharmaceuticals Inc ARZ.TO
* Aralez resubmits to FDA New Drug Application for Yosprala
* FDA is expected to issue Aralez an acknowledgment letter
within 30 days of resubmission
* If accepted, acknowledgement would also include a new
Prescription Drug User Fee Act date
Source text for Eikon: ID:nCNWBHSj7a
Further company coverage: ARZ.TO